2023 Insurance Coverage and Processing Specialty Pharmacies 
Proxsys Rx
APRIL 4, 2024
Why a Specialty Pharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
Proxsys Rx
AUGUST 22, 2023
Why a Specialty Pharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Proxsys Rx
DECEMBER 22, 2023
Why a Specialty Pharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
Putting Patients First Blog
JULY 2, 2024
We believe that patient-centric engagement is essential to ensure that the negotiation process leads to outcomes that genuinely benefit patients. Patient Engagement The NHC recognizes and commends CMS’ willingness to improve the listening sessions and the data submission processes. Improving the Data Collection (ICR) Process.
Putting Patients First Blog
JANUARY 27, 2025
Coverage of Anti-Obesity Medications (AOMs) The NHC applauds CMS for aligning with the medical community and proposing to recognize obesity as a chronic disease and allow Medicare Part D coverage for AOMs. Below, we provide detailed comments and recommendations on key provisions of the proposed rule.
Pharmacy Times
JULY 1, 2025
Rilonacept therapy management involves carefully evaluating patient disease stability, flare risks, and potential for discontinuation through a shared decision-making process. In an interview with Pharmacy Times ®, Allan L. We on our own help to navigate patients through that process as well. Some people even want to stay on it.
Pharmacy Times
JULY 1, 2025
SHOW MORE Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis. Additionally, pharmacists are also vital in identifying financial assistance programs or navigating specialty pharmacies or mail-order services.
Expert insights. Personalized for you.
52 
Let's personalize your content